Chief, Skeletal Clinical Studies Unit
National Institutes of Health
Building 30, Room 228 MSC 4320
Bethesda, MD 20892-4320
Phone: (301) 496-4913
Fax: (301) 402-0824
E-mail: mc247k@nih.gov
Research Interests
Bone and mineral metabolism, fibrous dysplasia of bone/McCune-Albright syndrome, fibroblast growth factor-23, hypoparathyroid bone
Education
B.G.S. University of Maryland, College Park 1987
M.D. University of Maryland, Baltimore 1992
Recent Publications
Feuillan, P. K. Calis, S. Hill, T. Shawker, P. G. Robey, M. T. Collins, Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome; a pilot study,2007, J Clin Endo and Metab 92(6) 2100-2106
Khosravi, A, C.M. Cutler, M.H. Kelly, R. Chang, R.E. Royal, R.M. Sherry, F.M. Wodajo, N.S. Fedarko, M.T. Collins, Determination of the elimination half life of FGF-23,2007, J Clin Endo and Metab, 92, 2374-2377.
Hart, E.S., M.H. Kelly, B. Brillante, C.C. Chen, N. Ziran, J.S. Lee, P. Feuillan, A.I. Leet, H.Kushner, P.G. Robey, M.T. Collins, Onset, Progression, and Plateau of Skeletal Lesions in Fibrous Dysplasia, and the Relationship to Functional Outcome,2007, J Bone and Miner Res, 22, 1468-1474.
Kelly, M.H., B. Brillante, M. T. Collins, Age related changes in pain prevalence and the anatomical distribution of skeletal lesions in fibrous dysplasia Osteoporosis International 2008, 19(1):57-63.
Michienzi, S., N. Cherman, K. Holmbeck, A. Funari, M.T. Collins, P. Bianco, P.G. Robey. GNAS transcripts in skeletal progenitors: Evidence for random asymmetric allelic expression of Gsα Hum Mol Genet 2007 16(16):1921-30.
DeWitt, C. A., M.T. Collins, E.W. Cowen, Diffuse pain, hypophosphatemia, and a subcutaneous nodule, 2007, J Am Acad Dermatol, 57(3); 509-512.
Celi, F.S., G. Coppotelli, A. Chidakel, M. Kelly, B. A. Brillante, T. Shawker, N. Cherman, P. P. Feuillan, M. T. Collins. The role of type-1 and type-2 5’deiodinase in the pathophysiology of the T3 toxicosis of McCune-Albright syndrome, J Clin Endo and Metab, 2008 (in press)